We are N-(4-aminobenzoyl)-L-glutamic acid CAS:4271-30-1 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
|Items of Analysis||Standard of Analysis||Test Results|
|Appearance||White crystalline powder||Conform|
|Loss on drying||≤2.0%||0.34%|
|Residue on ignition||≤3.0%||1.10%|
|Conclusion||Conforms to Factory Standard|
Related News: The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.2-methyl-1-hydroxy-3-butanone oxime With the continuous accumulation of the API industry and the increasing maturity of the market, competition in China’s API industry will become increasingly fierce.4-chloro-3-propoxy-butyric acid propyl ester The KCDC said a 28-year-old man had tested positive. He was among the 368 repatriated South Koreans who arrived from Wuhan on a charter flight on January 31. The rest of the evacuees have tested negative for the coronavirus.62253-63-8 GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.
|Furan Cas:110-00-9||View Details|